KR100366302B1 - A METHOD OF PREPARING FERMENTED MILK USING EGG YOLK CONTAINING ANTI-Helicobacter pylori CHICKEN IgY - Google Patents

A METHOD OF PREPARING FERMENTED MILK USING EGG YOLK CONTAINING ANTI-Helicobacter pylori CHICKEN IgY Download PDF

Info

Publication number
KR100366302B1
KR100366302B1 KR1020000016916A KR20000016916A KR100366302B1 KR 100366302 B1 KR100366302 B1 KR 100366302B1 KR 1020000016916 A KR1020000016916 A KR 1020000016916A KR 20000016916 A KR20000016916 A KR 20000016916A KR 100366302 B1 KR100366302 B1 KR 100366302B1
Authority
KR
South Korea
Prior art keywords
antibody
fermented milk
weight
yolk
egg
Prior art date
Application number
KR1020000016916A
Other languages
Korean (ko)
Other versions
KR20000049499A (en
Inventor
김성훈
백영진
이정열
이정준
허철성
Original Assignee
주식회사 한국야쿠르트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19660718&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR100366302(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 주식회사 한국야쿠르트 filed Critical 주식회사 한국야쿠르트
Priority to KR1020000016916A priority Critical patent/KR100366302B1/en
Publication of KR20000049499A publication Critical patent/KR20000049499A/en
Priority to JP2001048462A priority patent/JP4489315B2/en
Application granted granted Critical
Publication of KR100366302B1 publication Critical patent/KR100366302B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

본 발명은 계란의 희석액에 유산균 성장촉진 물질을 첨가한 후 유산균을 접종하여 배양하는 종래의 기술과는 달리, 기존의 발효유 공정에 항 헬리코박터 필로리 항체가 함유된 난황액을 첨가하는 방법에 관한 것으로, 더욱 자세하게는 발효유 제조 공정 중 항 헬리코박터 필로리 항체역가의 유지뿐만 아니라 일반 미생물 및 효모 오염도 방지하기 위한 살균방법을 제공하고자 한다.The present invention relates to a method for adding an egg yolk solution containing an anti-helicobacter phyllori antibody to a conventional fermented milk process, unlike the conventional technique of adding a lactic acid bacteria growth promoting substance to an egg diluent and then inoculating the lactic acid bacteria. More specifically, it is intended to provide a sterilization method for preventing general microbial and yeast contamination as well as maintaining anti-Helicobacter pilori antibody titer during fermented milk manufacturing process.

Description

항 헬리코박터 필로리 항체를 함유한 난황액을 이용한 발효유 제조 방법{A METHOD OF PREPARING FERMENTED MILK USING EGG YOLK CONTAINING ANTI-Helicobacter pylori CHICKEN IgY}Fermented milk production method using egg yolk solution containing anti-Helicobacter pilori antibody {A METHOD OF PREPARING FERMENTED MILK USING EGG YOLK CONTAINING ANTI-Helicobacter pylori CHICKEN IgY}

본 발명은 항 헬리코박터 필로리 항체를 함유하는 난황액을 이용하여 발효유 제품을 제조할 때, 항체의 역가 유지와 일반 미생물 및 효모 오염을 방지할 수 있는 방법에 관한 것이다.The present invention relates to a method capable of maintaining titers of antibodies and preventing general microorganisms and yeast contamination when a fermented milk product is prepared using an egg yolk solution containing an anti-Helicobacter pilori antibody.

최근 위궤양 원인균으로 알려진 헬리코박터 필로리에 대한 항원을 산란계에 주사하여, 이 항원으로부터 난황으로 이행된 항체를 유효성분으로 사용하는 연구가 활발히 이루어지고 있다. 일본 특개평 4-275232는 헬리코박터 필로리 균체 파쇄액을 항원으로 하여 생성된 항체를 유효성분으로 위궤양, 십이지장궤양 예방식품에 관해 개시하고 있다. 국내 특허 공고 98-81323에서는 헬리코박터 필로리 우레아제(urease)와 플라겔라(flagella)에 대해 면역화된 난황항체를 0.01∼0.1중량% 함유하고 락트산 박테리아, 엔테로코쿠스, 이스트 및 바실러스로부터 선택된 유기체를 함유하는 위염, 위궤양 및 십이지장궤양 예방, 치료용 약학적 조성물에 대해 개시하고 있다. 그러나 상기의 특허들로부터 만들어진 난황항체를 발효유, 음료 등의 제품에 이용할 경우 공정상 실시되는 열처리에 의해 특정항체들의 역가가 현저히 감소하게 되어, 난황항체에 의한 위궤양, 위염, 십이지장궤양의 예방과 치료효과를 기대하기는 힘들다. 이 같은 난황항체의 저장 중 역가유지를 위한 연구로는 쉬미쭈(Shimizu) 등이 저장이나 공정상 항체역가의 유지를 위해 30∼50 중량%의 자당(sucrose)나 설탕을 첨가하여 75∼80℃에서 15분간 열처리하였다고 보고하였다(J. of food science, 1994, 59(4), 763-772).Recently, an antigen against Helicobacter pylori, known as a causative agent for gastric ulcer, has been injected into a laying hen, and studies are actively conducted using an antibody transferred from the antigen to egg yolk as an active ingredient. Japanese Patent Laid-Open No. 4-275232 discloses a food for preventing gastric ulcer and duodenal ulcer as an active ingredient of an antibody produced by using Helicobacter pylori cell lysate as an antigen. Korean Patent Publication 98-81323 discloses 0.01 to 0.1% by weight of yolk antibodies immunized against Helicobacter pylori urease and flagella, and an organism selected from lactic acid bacteria, Enterococcus, yeast and Bacillus. A pharmaceutical composition for preventing and treating gastritis, gastric ulcer and duodenal ulcer is disclosed. However, when yolk antibodies made from the above patents are used in products such as fermented milk and beverages, the titer of specific antibodies is significantly reduced by heat treatment performed in the process, thereby preventing and treating gastric ulcer, gastritis and duodenal ulcer caused by yolk antibodies. It's hard to expect an effect. In order to maintain the titer of the yolk antibody during storage, Shimizu et al. Added 30-50% by weight of sucrose or sugar for storage or maintenance of antibody titer in the process, and the temperature was 75-80 ° C. Reported heat treatment for 15 minutes (J. of food science, 1994, 59 (4), 763-772).

한편 계란의 발효유에 대한 적용은 1984년 린(Lin)과 커닝햄(cunningham)이 47.4%의 난백에 구연산(citric acid)과 28.4%의 알칼리처리 대두유, 19.0%의 탈지유를 살균하여 혼합하고, 여기에 포도당(sucrose), 자당(sucrose), 잔탄 검(xanthan gum), 바닐라(vanilla) 추출물 등을 첨가한 후 락토바실러스 불가리커스(L. bulgaricus)와 스트렙토코커스 써모필러스(S. thermophilus)를 접종하여 요구르트를 개발하였다. 1984년 커닝햄(cunningham) 등은 저지방 균질유를 살균, 냉각하고, 여기에 54.4℃로 2회 살균한 난백 알부민(albumin)을 균질화하여 혼합한 후 락토바실러스 불가리커스와 스트렙토코커스 써모필러스를 혼합접종하여 40℃에서 6시간 배양하여 요구르트를 제조하였다. 또한 1983년 김 등은 58℃, 30분의 열처리 조건으로 균질 전란액에 포도당, 자당, 유당을 첨가하고, 유산균을 첨가하여 pH를 4.8까지 낮추어 발효유를 제조하였다. 일본의 경우 특허공고(공고번호 : 소 57-54113)에는 난백의 라이소자임(lysozyme)을 제거한 건조멸균난백을 우유에 용해하고, 포도당을 첨가한 후 유산균을 접종하여 발효유를 제조한다는 기술이 개시되어 있다. 국내 특허로는 유 등(공고번호 : 97-574)이 전란액, 난황액, 난백액에 유당, 설탕, 물을 혼합하여 살균한 후, 락토바실러스 애시도필러스, 비피도박테리움 롱검, 스트렙토코커스 써모필러스를 혼합 접종하여 발효시키는 유산균 발효 음료 제조방법을 개시하였다. 이상과 같이 계란을 이용한 발효유의 개발은 전란액, 난백, 난황의 희석액에 발효를 촉진시키기 위한 당, 알칼리 처리 대두유, 탈지유 등을 혼합하여 발효유를 제조하였으며, 발효유의 층분리 현상 등 물리적 안정성을 해결하기 위해 잔탄 검과 같은 안정제를 사용하였다.In 1984, Lin and Cunningham applied egg fermented milk by sterilizing 47.4% egg white, citric acid, 28.4% alkaline soybean oil, and 19.0% skim milk. Glucose (sucrose), sucrose (sucrose), xanthan gum, vanilla (vanilla) extracts were added, and then inoculated with L. bulgaricus and Streptococcus thermophilus Yogurt was developed. In 1984, Cunningham et al. Sterilized and cooled low-fat homogeneous oil, homogenized and mixed with egg white albumin (albumin) sterilized twice at 54.4 ° C, and then mixed inoculated Lactobacillus vulgaris and Streptococcus thermophilus. 6 hours at 40 ℃ to prepare a yogurt. In 1983, Kim et al. Prepared fermented milk by adding glucose, sucrose, and lactose to the homogeneous whole solution under a heat treatment condition of 58 ° C. for 30 minutes and lowering the pH to 4.8 by adding lactic acid bacteria. In the case of Japan, a patent publication (notice number: 57-54113) discloses a technique of preparing fermented milk by dissolving dry sterilized egg whites from which lysozyme of egg white is removed in milk, adding glucose, and then inoculating lactic acid bacteria. . Domestic patents include oils (notice: 97-574) sterilized by mixing lactose, sugar and egg whites with lactose, sugar, and water, and then lactobacillus ashdophyllus, Bifidobacterium longgum, and streptoco Disclosed is a method for preparing a lactic acid bacterium fermented beverage which is inoculated and mixed with Caucasus thermophilus. In the development of fermented milk using eggs as described above, fermented milk was prepared by mixing sugar, alkali-treated soybean oil, skim milk, etc. to promote fermentation in diluents of whole egg, egg white, and egg yolk, and solved physical stability such as layer separation phenomenon of fermented milk. To do this, stabilizers such as xanthan gum were used.

본 발명은 계란의 희석액에 유산균 성장촉진 물질을 첨가한 후 유산균을 접종하여 배양하는 종래의 기술과는 달리, 기존의 발효유 공정에 항 헬리코박터 필로리 항체가 함유된 난황액을 첨가하는 방법에 관한 것으로, 더욱 자세하게는 발효유 제조 공정 중 항 헬리코박터 필로리 항체역가의 유지뿐만 아니라 일반 미생물 및 효모 오염도 방지하기 위한 살균방법을 제공하고자 한다.The present invention relates to a method for adding an egg yolk solution containing an anti-helicobacter phyllori antibody to a conventional fermented milk process, unlike the conventional technique of adding a lactic acid bacteria growth promoting substance to an egg diluent and then inoculating the lactic acid bacteria. More specifically, it is intended to provide a sterilization method for preventing general microbial and yeast contamination as well as maintaining anti-Helicobacter pilori antibody titer during fermented milk manufacturing process.

본 발명은 헬리코박터 필로리 항원에 의해 면역화된 난황항체를 포함하는 난황액을 발효유 제조에 적용하는데 있어서, 이들이 가지고 있는 항체역가를 유지하는 동시에 일반 미생물 및 효모의 오염을 방지 할 수 있는 살균방법을 제공하는 것을 목적으로 한다.The present invention is applied to the yolk solution containing the yolk antibody immunized by the Helicobacter pylori antigen in the production of fermented milk, it provides a sterilization method that can prevent contamination of general microorganisms and yeast while maintaining the antibody titer they have It aims to do it.

도 1은 당 농도와 살균온도에 따른 항체역가 변화에 대한 그래프이다.1 is a graph showing the change in antibody titer according to sugar concentration and sterilization temperature.

도 2는 살균시간에 따른 항체역가와 미생물 오염도의 변화에 대한 그래프이다.Figure 2 is a graph of the change in antibody titer and microbial contamination according to the sterilization time.

도 3은 살균회수에 따른 항체역가와 미생물 오염도의 변화에 대한 그래프이다.Figure 3 is a graph of the change in antibody titer and microbial contamination according to the sterilization recovery.

도 4는 항 헬리코박터 필로리 항체가 함유된 난황액을 이용한 발효유의 제조공정도이다.Figure 4 is a manufacturing process of the fermented milk using an egg yolk solution containing an anti-helicobacter phyllori antibody.

본 발명자들은 헬리코박터 필로리를 항원으로 하여 산란계로부터 항체가 들어있는 면역란을 생산하였다. 이렇게 생산된 면역란으로부터 항체를 함유하고 있는 난황부분만을 분리하여 발효유 제조에 사용하고자 하였다. 그리고 난황액을 발효유 제품에 첨가하는데 있어서 일반미생물과 효모의 오염을 방지하고, 열처리 과정에서 항체역가의 감소를 방지하기 위한 살균조건을 연구하여 본 발명을 완성하게 되었다.The present inventors produced immune eggs containing antibodies from the laying hens using Helicobacter Philophyll as an antigen. Thus, only the yolk portion containing the antibody was separated from the produced immune eggs and used to prepare fermented milk. In addition, the present invention has been completed by studying sterilization conditions to prevent contamination of general microorganisms and yeasts in addition to yolk solution and fermented milk products, and to prevent reduction of antibody titers during heat treatment.

본 발명의 바람직한 일실시예에 따르면, 항 헬리코박터 필로리 항체가 함유된 난황액에 당을 첨가하여 항체역가를 유지하고 살균 열처리하여 일반미생물 및 효모의 오염을 방지한 후에 이 살균처리된 난황액을 유산균 배양액에 혼합하여 교반하여 발효유가 제조된다. 항체역가를 유지하기 위해서 사용되는 바람직한 당은 설탕, 고과당, 갈락토올리고당으로 이루어지는 군으로부터 선택된다. 보다 바람직하게는 당은 설탕이다.상기 70 내지 90중량% 난황액에 첨가되는 당의 함량은 10 내지 30중량%인 것이 바람직하다. 또한, 상기 살균 열처리는 60 내지 65℃에서 2내지 10분간 1회 내지 3회 행하여지는 것이 바람직하다.본 발명의 바람직한 실시예에 의하면, 80중량% 유산균배양액 및 10 내지 19.9중량% 과일시럽에 첨가되는 난황액의 함량은 0.1 내지 10중량%이다.항원의 준비 According to a preferred embodiment of the present invention, after adding the sugar to the yolk solution containing the anti-Helicobacter phyllori antibody to maintain the antibody titer and sterilization heat treatment to prevent contamination of the general microorganism and yeast after the sterilized yolk solution Fermented milk is prepared by mixing and stirring the lactic acid bacteria culture medium. Preferred sugars used to maintain antibody titers are selected from the group consisting of sugars, high fructose, galactooligosaccharides. More preferably, the sugar is sugar. The content of the sugar added to the 70 to 90% by weight yolk solution is preferably 10 to 30% by weight. In addition, the sterilization heat treatment is preferably performed once to three times at 60 to 65 ℃ for 2 to 10 minutes. According to a preferred embodiment of the present invention, it is added to the 80% by weight lactic acid culture medium and 10 to 19.9% by weight fruit syrup The content of the yolk solution is 0.1 to 10% by weight. Preparation of the antigen

위궤양의 원인균으로 알려진 헬리코박터 필로리를 초음파로 파쇄한 후 원심분리하여 상등액을 얻었다. 이 상등액을 초원심분리하여 세포막을 침전시킨 후 증류수에 현탁시켜 항원으로 사용하였다(실시예 1 참조).Helicobacter Philosophy, known as the causative agent of gastric ulcers, was disrupted with ultrasound and centrifuged to obtain supernatant. The supernatant was ultracentrifuged to precipitate cell membranes, which were then suspended in distilled water and used as antigens (see Example 1).

항 헬리코박터 필로리 항체가 함유된 난황액 제조Preparation of Egg Yolk Containing Anti-Helicobacter Philoly Antibody

외막단백질 항원을 이용하여 40주된 백색 레그혼에 면역을 실시하였다. 아주반트, 유화제, 항원을 9 : 1 : 8의 비율로 혼합하여 유화시킨 후 충분한 항체가 얻어질 때까지 2주 간격으로 4회 근육 주사하였다. 계란으로 이행된 특이적 항체의역가가 충분히 상승한 단계의 계란을 수거하였다. 수거한 면역란을 할란기를 통해 난백과 난황으로 분리하고, 분리된 난황을 filter로 여과한 후 70∼80 kg/㎠로 균질하여 난황액을 제조하였다. 이렇게 제조된 난황액의 항 헬리코박터 필로리 항체역가는 약 5,700 정도로 나타났다(실시예 2, 3 참조).The 40-week-old white leghorn was immunized with the envelope protein antigen. The adjuvant, emulsifier, and antigen were mixed and emulsified in a ratio of 9: 1: 8, and then injected intramuscularly four times at two-week intervals until sufficient antibodies were obtained. Eggs were harvested at which the titers of specific antibodies transferred to eggs were sufficiently elevated. The collected immune eggs were separated into egg whites and egg yolks through the harlans, and the separated egg yolks were filtered with a filter and then homogeneous at 70 to 80 kg / cm 2 to prepare egg yolk solutions. The anti-Helicobacter pilori antibody titer of the yolk solution thus prepared was about 5,700 (see Examples 2 and 3).

당 농도와 살균온도에 따른 항체역가Antibody Titer According to Sugar Concentration and Sterilization Temperature

난황액의 저장성을 높이고 항체역가의 감소를 방지하기 위해 설탕의 농도와 살균온도에 따른 항체역가 변화를 확인하였다. 그 결과 10 중량% 설탕을 함유하는 90 중량% 난황액을 63℃이하의 살균온도에서 10분간 처리하는 것이 항 헬리코박터 필로리 항체의 역가를 80% 이상 유지할 수 있는 것으로 나타났다(실시예 4 참조).In order to improve the shelf life of egg yolk solution and to reduce the antibody titer, the antibody titer was changed according to sugar concentration and sterilization temperature. As a result, it was shown that treatment of 90 wt% yolk solution containing 10 wt% sugar at a sterilization temperature of 63 ° C. or less for 10 minutes can maintain the titer of the anti-Helicobacter pilori antibody at least 80% (see Example 4).

살균 시간에 따른 항체역가 및 오염도Antibody Titer and Contamination with Sterilization Time

특히 10중량% 설탕을 첨가한 90중량 %난황액을 63℃에서 3, 5, 7, 10분간 각각 살균한 후 항 헬리코박터 필로리 항체역가와 일반미생물 및 효모 오염도를 측정하였다. 그 결과 63℃에서 5분까지 얼처리한 경우, 항체 역가가 90% 이상 유지되는 것으로 나타났으며, 오염도 측정결과 7분 이상의 열처리에 의해서만 일반미생물과 효모가 완전히 사멸되는 것을 확인할 수 있었다(실시예 5 참조).In particular, 90 wt% yolk sac with 10 wt% sugar was sterilized at 63 ° C. for 3, 5, 7, and 10 minutes, and then the anti-Helicobacter pylori antibody titer and general microbial and yeast contamination were measured. As a result, when the annealing up to 5 minutes at 63 ℃, the antibody titer was maintained at 90% or more, and as a result of the contamination measurement, it was confirmed that the general microorganism and yeast are completely killed only by heat treatment for 7 minutes or more (Example 5).

살균회수에 따른 항체역가 및 오염도Antibody Titer and Contamination by Sterilization Count

10중량% 설탕을 첨가한 90중량% 난황액을 63℃, 3분의 열처리 조건으로 3회까지 살균하면서 항체역가의 변화와 오염도를 확인하였다. 그 결과 항 헬리코박터 필로리 항체역가는 2회 살균할 때까지 95% 이상 유지되었으며, 일반 미생물과 효모의 오염도도 2회 살균시 대부분 억제되는 것으로 나타났다. 따라서 난황액의 항체역가 유지와 함께 미생물의 오염을 방지하기 위해서는 63℃에서 3분씩 2회에 걸쳐 살균하는 것이 보다 효과적임을 확인하였다(실시예 6 참조).The 90 wt% yolk solution added with 10 wt% sugar was sterilized up to three times under heat treatment conditions of 63 ° C. for 3 minutes to confirm changes in antibody titers and contamination. As a result, the anti-H. Pylori antibody titer was maintained at 95% or more until 2 times sterilization, and the contamination of general microorganisms and yeast was also suppressed mostly in 2 times sterilization. Therefore, in order to prevent the contamination of microorganisms together with the maintenance of the antibody titer of the yolk sac solution, it was confirmed that sterilization twice in three minutes at 63 ℃ (see Example 6).

난황액을 이용한 발효유 제조Fermented milk production using egg yolk

항 헬리코박터 필로리 항체가 함유된 난황액을 이용하여 발효유를 제조하였다. 살균된 원료유에 락토바실러스 애시도필러스와 락토바실러스 카제이, 스트렙토코거스 써모필러스, 비피도박테리움 롱검을 일정 농도로 접종하여 pH 4.5가 될 때까지 배양한 후 냉각시켰다. 그리고 과즙농축액, 식이섬유, 포도당, 올리고당 등을 녹여 시럽을 제조하였다. 10중량% 설탕을 첨가한 90중량% 난황액을 63℃에서 3분간 2회 살균처리하고, 상기 살균처리된 0.1 내지 10중량% 난황액을 80중량% 유산균배양액과 상기에서 제조된 10 내지 19.9중량% 시럽과 혼합하여 교반하였다. 여기에 미리 제조된 시럽을 일정 비율로 혼합, 교반하여 균질화 시킨 후 용기에 포장하였다. 이렇게 특정 항체를 유효성분으로 함유하고 있는 난황이 첨가된 발효유를 관능검사한 결과 풍미, 물성, 전체적인 맛에 있어서 양호한 결과를 보였다(실시예 7 참조).Fermented milk was prepared using an egg yolk solution containing anti-Helicobacter pilori antibody. Lactobacillus ashdophyllus, Lactobacillus cassia, Streptococcus thermophilus, Bifidobacterium longgum were inoculated to sterilized raw milk to incubate at a constant concentration and cooled to pH 4.5. And the syrup was prepared by dissolving the juice concentrate, dietary fiber, glucose, oligosaccharide, and the like. 90 wt% yolk solution added with 10 wt% sugar was sterilized twice at 63 ° C. for 3 minutes, and the sterilized 0.1 to 10 wt% yolk solution was cultured with 80 wt% lactic acid bacteria and 10 to 19.9 wt% prepared above. Stir with% syrup. Here, the pre-prepared syrup was mixed, stirred and homogenized at a predetermined ratio, and then packed in a container. As a result of sensory evaluation of fermented milk containing egg yolk containing a specific antibody as an active ingredient, the result was satisfactory in flavor, physical properties and overall taste (see Example 7).

이하 실시예를 통해 본 발명을 보다 상세하게 설명한다. 그러나 다음의 실시예는 본 발명의 범위를 한정하는 것은 아니며, 본 발명의 기술적 사상의 범위 내에서 당업자에 의한 통상적인 변화가 가능하다.The present invention will be described in more detail with reference to the following Examples. However, the following examples are not intended to limit the scope of the present invention, and ordinary changes by those skilled in the art are possible within the scope of the technical idea of the present invention.

실시예 1Example 1

항원의 준비Preparation of the antigen

헬리코박터 필로리를 5% 마혈청을 함유하는 브루셀라(Brucella) 배지에서 37℃, 2일간 배양하였다. 이 배양액을 4,000×g에서 원심분리하여 균체를 회수한 후 인산완충생리식염수에 현탁시켰다. 초음파로 균체를 파쇄한 후 10,000×g에서 20분간 원심분리하여 파쇄되지 않은 균체를 제거한 다음 회수한 상등액을 100,000×g로 30분간 초원심분리하여 세포막을 침전시킨 후 증류수에 현탁시켜 항원으로 사용하였다.Helicobacter pylori was incubated for 2 days at 37 ° C. in Brucella medium containing 5% horse serum. The culture was centrifuged at 4,000 × g to recover the cells and then suspended in phosphate buffered saline. The cells were crushed by ultrasound, centrifuged at 10,000 × g for 20 minutes to remove the unbroken cells, and the recovered supernatants were ultracentrifuged at 100,000 × g for 30 minutes to precipitate cell membranes, which were then suspended in distilled water and used as antigens. .

실시예 2Example 2

항 헬리코박터 필로리 항체의 제조Preparation of Anti Helicobacter Philoly Antibody

실시예 1에서 제조한 외막단백질 항원을 이용하여 백색 레그혼에 면역을 실시하였다. 아주반트는 미네랄 오일의 일종인 드라케올(Drakeol)과 유화제를 혼합하여 사용하고, 유화제로는 스판 85(Span 85) 및 트윈 85 (Tween 85)를 54:46의 비율로 혼합하여 사용하였다. 드라케올, 유화제, 항원을 9 : 1 : 8의 비율로 혼합하여 유화시킨 후 충분한 항체가가 얻어질 때까지 2주 간격으로 4회 근육 주사하였다. 계란으로 이행된 특이적 항체 역가 추이를 추적하여 항체 역가가 충분히 상승한 단계의 계란을 채취하여 난황액을 제조하였다.The white leghorn was immunized using the outer membrane protein antigen prepared in Example 1. The adjuvant was used by mixing Drakeol, which is a kind of mineral oil, with an emulsifier, and using Span 85 and Tween 85 at a ratio of 54:46. Drakeol, emulsifier, and antigen were mixed and emulsified in a ratio of 9: 1: 8, and then intramuscularly injected four times at two week intervals until sufficient antibody titer was obtained. The yolk solution was prepared by tracking the specific antibody titer transition to the egg and collecting the eggs at the stage where the antibody titer was sufficiently elevated.

간격으로 4회 근육주사하였다. 계란으로 이행된 특이적 항체의 역가가 충분히 상승한 단계의 계란을 수거하였다. 수거한 면역란을 할란기를 통해 난백과 난황으로 분리하고, 분리된 난황을 filter로 여과한 후 70∼80 kg/㎠로 균질하여 난황액을 제조하였다.Four intramuscular injections were made at intervals. Eggs were harvested at which the titer of the specific antibody transferred to the eggs was sufficiently elevated. The collected immune eggs were separated into egg whites and egg yolks through the harlans, and the separated egg yolks were filtered with a filter and then homogeneous at 70 to 80 kg / cm 2 to prepare egg yolk solutions.

실시예 3Example 3

항체가의 측정Antibody titration

난황중의 항 헬리코박터 필로리 항체가는 마이크로타이터법에 의해 다음과 같이 측정하였다. 난황액 1g과 람다 카라기난 수용액(0.15% w/v) 9ml을 혼합하여 실온에서 30분간 방치후 10,000×g, 10분간 원심분리를 하여 특이적 항체를 함유하는 난황수용성 단백분획을 얻어 시료액으로 하였다. 시료액을 인산완충액(PBS, pH 7.4)로 2n배 희석하여 검액으로 하였다. 응집항체가는 각 검액 50㎕와 균파쇄액 50㎕를 마이크로플레이트에 혼합한 후 37℃, 24시간 정치하여 응집의 유무를 조사하므로서 이루어진다. 항체역가는 응집이 보여지는 샘플의 최대 희석배율의 역수로 나타내었다. 실시예 2에 의해 제조된 난황액의 항체역가는 약 5,700 정도로 나타났다.Anti-helicobacter phyllori antibody titer in egg yolk was measured by the microtiter method as follows. 1 g of egg yolk solution and 9 ml of lambda carrageenan solution (0.15% w / v) were mixed and left at room temperature for 30 minutes, followed by centrifugation at 10,000 × g for 10 minutes to obtain an aqueous yolk soluble protein fraction containing a specific antibody. . The sample solution was diluted 2n times with phosphate buffer (PBS, pH 7.4) to prepare a sample solution. Agglutinated antibody titer is obtained by mixing 50 μl of each sample solution and 50 μl of bacterial crushed solution on a microplate, and then standing at 37 ° C. for 24 hours to investigate the presence of aggregation. Antibody titers were expressed as the inverse of the maximum dilution factor of the sample in which aggregation was seen. The antibody titer of the yolk solution prepared by Example 2 was about 5,700.

실시예 4Example 4

당 농도와 살균온도에 따른 항체역가Antibody Titer According to Sugar Concentration and Sterilization Temperature

난황액의 저장성을 높이기 위해서는 살균공정이 필수적이다. 그러나 이 살균공정의 열처리 조건에 의해 항체의 역가가 감소할 수 있다. 따라서 살균공정에 따른 항체역가 감소를 방지하기 위해 설탕을 여러 농도로 첨가한 후 살균온도에 따른 항체역가 변화를 다음과 같이 확인하였다. 먼저 100, 90, 80, 70, 60 중량% 난황액에 각각 설탕을 0, 10, 20, 30, 40 중량%의 농도로 첨가하고, 각각의 난황액을 tubular type의 살균기를 이용하여 60, 63, 65, 67℃에서 10분간 살균처리하였다. 살균처리 후 실시예 3의 방법에 따라 항체역가의 변화를 확인하였다.Sterilization is essential to increase shelf life of yolk solution. However, due to the heat treatment conditions of the sterilization process, the titer of the antibody may decrease. Therefore, in order to prevent the decrease in antibody titer according to the sterilization process, after changing the sugar titer at various concentrations, the change in antibody titer according to the sterilization temperature was confirmed as follows. First, sugar is added to 100, 90, 80, 70, and 60% by weight of egg yolk solution at concentrations of 0, 10, 20, 30, and 40% by weight, respectively, and each yolk solution is prepared using a tubular type sterilizer. Sterilized at 65 ° C, 67 ° C for 10 minutes. After the sterilization treatment, the change in antibody titer was confirmed according to the method of Example 3.

도.1에서 보는 바와 같이 10 중량% 이상의 설탕을 90 중량% 미만의 난황액에 첨가하여 63℃ 이하의 살균온도에서 처리할 경우 항체역가가 약 80% 이상 유지되는 것으로 나타났다.As shown in Fig. 1, the antibody titer was maintained at about 80% or more when more than 10% by weight of sugar was added to less than 90% by weight of yolk solution and treated at a sterilization temperature of 63 ° C or lower.

실시예 5Example 5

살균 시간에 따른 항체역가 및 오염도Antibody Titer and Contamination with Sterilization Time

실시예 5에서 설정된 63℃에서 살균시간에 따른 항체역가와 일반미생물 및 효모의 오염도를 확인하였다. 먼저 난황액을 63℃에서 3, 5, 7, 10분간 각각 살균한 후 실시예 3의 방법에 따라 항체역가를 측정하였다. 동시에 살균시간별 시료 1ml을 취하여 10진 연속 희석하였다. 희석액 1ml을 페트리 디쉬에 접종하고 PCA(plate count agar, Difco, #0479-17) 배지를 분주하여 굳힌 후 37℃에서 2일간 배양하여 나타난 집락수를 일반 미생물로 계수하였다. 그리고 희석액 1ml을 페트리 디쉬에 접종하여 PDA(potato dextrose agar, Difco, #0013-17-6)배지를 분주하고 25℃에서 4일간 배양하여 나타난 집락수를 효모수로 계수하였다.The antibody titer and the degree of contamination of the general microorganism and the yeast according to the sterilization time at 63 ° C. set in Example 5 were confirmed. First, the yolk solution was sterilized at 63 ° C. for 3, 5, 7, and 10 minutes, and antibody titers were measured according to the method of Example 3. At the same time, 1 ml of the sterilized samples were taken and serially diluted. 1 ml of the dilution solution was inoculated in a Petri dish, and the PCA (plate count agar, Difco, # 0479-17) medium was dispensed and hardened, followed by incubation for 2 days at 37 ° C. 1 ml of the diluted solution was inoculated in a petri dish, and the PDA (potato dextrose agar, Difco, # 0013-17-6) medium was dispensed and cultured at 25 ° C. for 4 days to count the number of colonies as yeast water.

도.2에서 보는 바와 같이 63℃에서 5분까지 열처리한 경우 항 헬리코박터 필로리 항체의 역가는 90% 이상 유지되는 것으로 나타났다. 그러나 오염도 측정결과 7분 이상의 열처리에 의해서만 일반미생물과 효모가 완전히 사멸되는 것을 확인할 수 있었다.As shown in Fig. 2, when heat treated at 63 ° C. for 5 minutes, the titer of the anti-Helicobacter pilori antibody was maintained at 90% or more. However, it was confirmed that general microorganisms and yeast were completely killed only by heat treatment for more than 7 minutes.

실시예 6Example 6

살균회수에 따른 항체역가 및 오염도Antibody Titer and Contamination by Sterilization Count

실시예 5에서 항체의 역가 유지되는 살균조건이 63℃, 5분으로 나타났으나, 이 살균조건으로는 일반 미생물과 효모의 오염을 방지할 수 없기 때문에 살균회수를 늘리는 방안을 검토하였다. 10 중량%의 설탕이 첨가된 90중량%의 난황액을 63℃, 3분의 열처리 조건으로 3회까지 살균하면서 항체역가의 변화와 오염도를 확인하였다. 도.3에서 보는 바와 같이 항체역가의 유지는 2회 살균할 때까지 그대로 유지되었으며, 일반 미생물과 효모의 오염도도 2회 살균시 대부분 억제되는 것으로 나타났다. 따라서 난황액의 항체역가 유지와 함께 미생물의 오염을 방지하기 위해서는 63℃에서 계속적으로 열처리를 하는 것보다 3분씩 2회 걸쳐 살균하는 것이 보다 효과적임을 확인하였다.In Example 5, the sterilization condition for maintaining the titer of the antibody was 63 ℃, 5 minutes, but the sterilization conditions can not prevent the contamination of the general microorganism and yeast, the method to increase the number of sterilization was examined. 90 wt% of the yolk solution with 10% by weight of sugar was sterilized up to three times under heat treatment conditions of 63 ° C. for 3 minutes to confirm changes in antibody titers and contamination. As shown in Figure 3, the maintenance of the antibody titer was maintained as it is until two sterilization, the contamination of the general microorganism and yeast also appeared to be mostly suppressed in two sterilization. Therefore, in order to prevent the contamination of the microorganism with the maintenance of the antibody titer of the yolk solution, it was confirmed that sterilization twice over three minutes than the continuous heat treatment at 63 ℃.

실시예 7Example 7

난황액을 이용한 발효유 제조Fermented milk production using egg yolk

항 헬리코박터 필로리 항체가 함유된 난황액을 이용하여 도.4와 같이 발효유를 제조하였다. 먼저 탈지분유를 이용하여 무지유고형분 함량을 8.5 중량%로 조정한 원료유를 75℃에서 15초간 살균하였다. 살균된 원료유를 일정온도까지 냉각한 후 락토바실러스 애시도필러스와 락토바실러스 카제이, 스트렙토코거스 써모필러스, 비피도박테리움 롱검을 106 cfu/ml의 농도로 접종하여 pH 4.5가 될 때까지 배양한 후 냉각시켰다. 그리고 과즙농축액 1.0 중량%, 식이섬유 0.8 중량%, 포도당 7 중량%, 올리고당 6 중량% 등을 85.2 중량% 물에 녹여 시럽을 제조하였다. 이렇게 제조된 시럽을 살균한 후 냉각하였다. 한편 10 중량%의 설탕을 첨가한 90 중량%의 난황액을 63℃에서 3분간 2회 살균처리하였다. 상기 살균처리된 난황액 1.0 중량%를 상기 80중량%의 유산균 배양액과 미리 제조된 19.0중량%의 시럽을 혼합, 교반하여 균질화 시킨 후 용기에 포장하였다. 이렇게 특정 항체를 유효성분으로 함유하고 있는 난황이 첨가된 발효유를 관능검사한 결과 풍미, 물성, 전체적인 맛에 있어서 양호한 결과를 보였다.Fermented milk was prepared as shown in Fig. 4 using an egg yolk solution containing an anti-Helicobacter pilori antibody. First, raw milk with a nonfat milk content adjusted to 8.5% by weight using skim milk powder was sterilized at 75 ° C. for 15 seconds. After cooling the sterilized raw oil to a certain temperature, inoculating Lactobacillus ashdophyllus, Lactobacillus cassia, Streptocogus thermophilus, Bifidobacterium longgum at a concentration of 106 cfu / ml until pH 4.5 After incubation it was cooled. And the juice concentrate 1.0% by weight, dietary fiber 0.8% by weight, glucose 7% by weight, oligosaccharides 6% by weight, etc. dissolved in 85.2% by weight of water to prepare a syrup. The syrup thus prepared was sterilized and then cooled. On the other hand, 90% by weight of the yolk solution to which 10% by weight of sugar was added was sterilized twice at 63 ° C for 3 minutes. 1.0% by weight of the sterilized yolk solution was mixed with the 80% by weight of the lactic acid bacteria culture medium and 19.0% by weight of the syrup prepared in advance, homogenized by stirring, and then packaged in a container. As a result of sensory evaluation of fermented milk containing egg yolk containing a specific antibody as an active ingredient, the results were satisfactory in flavor, physical properties and overall taste.

상기 실시예들에서 확인된 바와 같이, 본 발명에 따른 난황액의 열처리 공정은 항 헬리코박터 필로리 항체의 역가가 그대로 유지되면서 일반 미생물과 효모의 오염을 억제할 수 있었다. 따라서 본 발명에 의하면 항 헬리코박터 필로리 항체 역가를 유지하고 있는 난황액을 이용하여 발효유를 제조할 수 있다.As confirmed in the above embodiments, the heat treatment process of the yolk solution according to the present invention was able to suppress contamination of general microorganisms and yeast while maintaining the titer of the anti-Helicobacter pilori antibody. Therefore, according to the present invention, fermented milk can be prepared using an egg yolk solution that maintains the anti-Helicobacter pilori antibody titer.

Claims (5)

발효유 제조방법에 있어서,In the fermented milk manufacturing method, 항 헬리코박터 필로리 항체가 함유된 70 내지 90중량% 난황액에 설탕, 고과당, 갈락토올리고당으로 이루어지는 군으로부터 선택되는 중량비 10 내지 30중량%인 당을 첨가하여 항체역가를 유지하는 단계;Maintaining the antibody titer by adding a sugar having a weight ratio of 10 to 30% by weight selected from the group consisting of sugar, high fructose and galactooligosaccharides to 70 to 90% by weight yolk solution containing an anti-Helicobacter pilori antibody; 상기 당이 첨가된 난황액을 60 내지 65℃에서 2 내지 10분간 1회 내지 3회 살균 열처리 일반미생물 및 효모의 오염을 방지하는 단계;Preventing the contamination of the microorganisms and yeasts in which the sugar-added yolk solution is sterilized by one to three times at 60 to 65 ° C. for 2 to 10 minutes; 상기 살균처리된 난황액을 유산균배양액과 시럽에 혼합하여 교반하는 단계를 포함하는 것을 특징으로 하는 발효유 제조방법.Fermented milk production method comprising the step of mixing and stirring the sterilized yolk solution in the lactic acid bacteria culture solution and syrup. 삭제delete 삭제delete 삭제delete 제1항에 있어서, 혼합 교반되는 상기 유산균배양액은 80중량%이고, 상기 시럽은 10 내지 19.9중량%이고, 첨가되는 상기 살균처리된 난황액은 0.1 내지 10중량%인 것을 특징으로 하는 발효유 제조방법.The method of claim 1, wherein the mixed lactic acid bacteria culture solution is stirred at 80% by weight, the syrup is 10-19.9% by weight, and the sterilized egg yolk solution added is 0.1-10% by weight. .
KR1020000016916A 2000-03-31 2000-03-31 A METHOD OF PREPARING FERMENTED MILK USING EGG YOLK CONTAINING ANTI-Helicobacter pylori CHICKEN IgY KR100366302B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020000016916A KR100366302B1 (en) 2000-03-31 2000-03-31 A METHOD OF PREPARING FERMENTED MILK USING EGG YOLK CONTAINING ANTI-Helicobacter pylori CHICKEN IgY
JP2001048462A JP4489315B2 (en) 2000-03-31 2001-02-23 Method for producing fermented milk using egg yolk liquid containing anti-Helicobacter pylori antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020000016916A KR100366302B1 (en) 2000-03-31 2000-03-31 A METHOD OF PREPARING FERMENTED MILK USING EGG YOLK CONTAINING ANTI-Helicobacter pylori CHICKEN IgY

Publications (2)

Publication Number Publication Date
KR20000049499A KR20000049499A (en) 2000-08-05
KR100366302B1 true KR100366302B1 (en) 2003-01-09

Family

ID=19660718

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020000016916A KR100366302B1 (en) 2000-03-31 2000-03-31 A METHOD OF PREPARING FERMENTED MILK USING EGG YOLK CONTAINING ANTI-Helicobacter pylori CHICKEN IgY

Country Status (2)

Country Link
JP (1) JP4489315B2 (en)
KR (1) KR100366302B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030012560A (en) * 2001-08-01 2003-02-12 주식회사 리앤조바이오텍 Functional soybean milk and method for preparing thereof
KR100485269B1 (en) * 2002-10-22 2005-04-29 주식회사 에그 바이오택 The production method of kimchi containing immunoglobulin y for e.coli, helicobacter pylori and thereof kimchi
WO2012020904A1 (en) * 2010-08-11 2012-02-16 Yoo Ickjong Lactic acid-fermented egg having reduced egg protein antigenicity through addition of sodium citrate, heating treatment, and lactic acid fermentation, and method for preparing same

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020021545A (en) * 2000-09-15 2002-03-21 이은선 FERMENTED MILK, MILK, ICECREAM USING EGG YOLK HAVING IgY, AND ITS METHOD FOR PREPARING
KR100392904B1 (en) * 2001-01-12 2003-07-28 매일유업주식회사 Composition containing egg yolk antibody, and food containing it
KR20020093410A (en) * 2001-06-08 2002-12-16 (주)두솔 Functional silken tofu and method for preparing thereof
KR100403282B1 (en) * 2001-06-29 2003-10-30 주식회사 에그 바이오택 The formulation for production of IgY products containing anti-Helicobacter pylori and anti-E.coli IgY, aloe powder, green tee extracts powder, and perilla powder to inhibit the growth of Helicobacter pylori
KR100785666B1 (en) * 2001-08-01 2007-12-14 농업회사법인 오보바이오 주식회사 Functional pudding and method for preparing thereof
KR100542484B1 (en) * 2001-12-28 2006-01-16 주식회사 에그 바이오택 THE PRODUCTION METHOD OF EGG CONTAINING IgY ABOUT ETEC, Salmonella enteritidis, Salmonella typhimurium, Helicobacter pylori AND THEREOF ICE CREAM OR YOGHURT EGG YOLK, EGG YOLK POWDER AND MIXING IgY POWDER WHICH IS EXTRACTED ABOVE EGG
JP2006014654A (en) * 2004-07-01 2006-01-19 Asama Chemical Co Ltd Antibody-containing food
JP2007053930A (en) * 2005-08-23 2007-03-08 Asama Chemical Co Ltd Method for producing antibody-containing fermented food
CN106465749B (en) * 2015-08-14 2019-11-08 内蒙古伊利实业集团股份有限公司 A kind of acidified milk and preparation method thereof containing egg yolk liquid

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030012560A (en) * 2001-08-01 2003-02-12 주식회사 리앤조바이오텍 Functional soybean milk and method for preparing thereof
KR100485269B1 (en) * 2002-10-22 2005-04-29 주식회사 에그 바이오택 The production method of kimchi containing immunoglobulin y for e.coli, helicobacter pylori and thereof kimchi
WO2012020904A1 (en) * 2010-08-11 2012-02-16 Yoo Ickjong Lactic acid-fermented egg having reduced egg protein antigenicity through addition of sodium citrate, heating treatment, and lactic acid fermentation, and method for preparing same

Also Published As

Publication number Publication date
KR20000049499A (en) 2000-08-05
JP2001275561A (en) 2001-10-09
JP4489315B2 (en) 2010-06-23

Similar Documents

Publication Publication Date Title
KR100324441B1 (en) Food for preventing gastritis, gastric and duodenal ulcers
Tamime et al. Microbiological and technological aspects of milks fermented by bifidobacteria
US4187321A (en) Method for producing foods and drinks containing bifidobacteria
Patton et al. Human disease associated with" Campylobacter upsaliensis"(catalase-negative or weakly positive Campylobacter species) in the United States
RU2247569C2 (en) Strain lactobacillus paracasei cncm i-2116 (ncc 2461) eliciting ability to prevent colonization of intestine with diarrhea-causing pathogenic microorganisms and to prevent infection of intestine epithelial cells with rotaviruses, foodstuff and pharmaceutical composition for prophylaxis and/or treatment of diarrhea-associated diseases
Vedamuthu Starter cultures for yogurt and fermented milks
KR100366302B1 (en) A METHOD OF PREPARING FERMENTED MILK USING EGG YOLK CONTAINING ANTI-Helicobacter pylori CHICKEN IgY
JPH04211360A (en) New lactic acid bacterium, antimicrobial substance produced thereby, starter for fermenting milk containing the same bacterium and production of fermented milk using the same starter
AU2018410430B2 (en) Lactobacillus reuteri SS23-52, preparation method of dry powder starter thereof, and application thereof in purebred probiotic yogurt
Sriphannam et al. A selected probiotic strain of Lactobacillus fermentum CM33 isolated from breast-fed infants as a potential source of β-galactosidase for prebiotic oligosaccharide synthesis
US20030185856A1 (en) Method for the production of the egg containing anti-pathogenic bacteria specific antbodies(igy) and the yogurt and ice cream containing the igy
US5185321A (en) Process for producing immunostimulants
Sakai et al. Mortality of bifidobacteria in boiled yogurt
KR100421309B1 (en) Fruit juice containing specific IgY for anti-E.coli and anti-Helicobacter pylori
EP2953476B1 (en) Use of skim milk as a carrier for a composition comprising lactobacillus
CN101475918B (en) Lactobacillus casei capable of reducing beta-lactoglobulin antigen antigenicity in cow's milk and use thereof
KR100422074B1 (en) The method for production of egg containing anti-E.coli IgY and anti-Helicobacter pylori IgY and anti-Salmonella enteritidis and Salmonella typhimurium simultaneously, and egg, yolk, yogurt and ice-cream containing specific IgY for anti-E.coli and anti-Helicobacter pylori and anti-Salmonella enteritidis and anti-Salmonella typhimurium
KR20020021545A (en) FERMENTED MILK, MILK, ICECREAM USING EGG YOLK HAVING IgY, AND ITS METHOD FOR PREPARING
JPH03151853A (en) Antibody and intestinal function controlling food containing the antibody as active component
KR100542484B1 (en) THE PRODUCTION METHOD OF EGG CONTAINING IgY ABOUT ETEC, Salmonella enteritidis, Salmonella typhimurium, Helicobacter pylori AND THEREOF ICE CREAM OR YOGHURT EGG YOLK, EGG YOLK POWDER AND MIXING IgY POWDER WHICH IS EXTRACTED ABOVE EGG
IE76730B1 (en) Method and product for the treatment of gastric disease
KR20090026849A (en) Efficient process for lactic acid beverage using egg
Occhino et al. A comparison of beta-galactosidase specific activities in strains of Streptococcus thermophilus
JPH05236945A (en) New bacterium belonging to genus lactobacillus
RU2123045C1 (en) Consortium of microorganisms lactobacillus acidophilus, lactobacillus delbruockii subspecies bulgaricus, saccharomyces for kumiss production

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20121204

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20131209

Year of fee payment: 12

J204 Request for invalidation trial [patent]
FPAY Annual fee payment

Payment date: 20141212

Year of fee payment: 13

J121 Written withdrawal of request for trial
FPAY Annual fee payment

Payment date: 20151211

Year of fee payment: 14

FPAY Annual fee payment

Payment date: 20161207

Year of fee payment: 15